Grasim Industries Limited Monitoring Agency Confirms Utilization of Rights Issue Proceeds

Grasim Industries Limited has received a clean report from its monitoring agency regarding the utilization of funds raised through its ₹3,999.80 crore Rights Issue. The assessment for the quarter ended March 31, 2026, confirms that the funds have been deployed in alignment with the objects stated in the offer document, with no deviations observed. All proceeds have been effectively allocated toward debt repayment and general corporate purposes.

Financial Utilization Update

Following the successful Rights Issue, Grasim Industries Limited has maintained full transparency in the deployment of raised capital. As of March 31, 2026, the monitoring agency confirmed that the company has utilized the proceeds strictly in accordance with the disclosures provided during the issue period. The total issue size of ₹3,999.80 crore was fully subscribed, ensuring the company met its strategic capital requirements.

Breakdown of Fund Deployment

The primary objects of the issue included the repayment or prepayment of specific company borrowings and funding for general corporate purposes. The utilization progress is as follows:

  • Debt Repayment: The company successfully allocated ₹3,000 crore toward the repayment or prepayment of existing borrowings, as originally proposed.
  • General Corporate Purposes (GCP): Out of the allocated ₹977.65 crore, the company has deployed ₹971.11 crore, leaving a nominal unutilized balance.

Operational Status

The report highlights that there have been no deviations or variations in the utilization of funds during the final quarter of the fiscal year. The company continues to operate within the defined parameters, with no delays noted in the implementation of the objects. The promoter shareholding, which stood at 42.75% prior to the issue, has increased to 43.74% as of March 31, 2026, reflecting stable management control and long-term confidence in the company’s growth trajectory.

Source: BSE

Previous Article

Niva Bupa Health Insurance Key Board Appointments and Leadership Elevation